In vivo development of quinolone resistance in Salmonella enterica serotype typhimurium DT104

J Clin Microbiol. 2003 Sep;41(9):4462-4. doi: 10.1128/JCM.41.9.4462-4464.2003.

Abstract

Salmonella enterica serotype Typhimurium definitive phage type 104 was isolated several times from the same patient over a period of 2 years. The strain developed reduced sensitivity to fluoroquinolones, and a mutation in the gyrA gene that is associated with reduced sensitivity to quinolones was identified.

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Ciprofloxacin / pharmacology*
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Middle Aged
  • Salmonella typhimurium / classification
  • Salmonella typhimurium / drug effects*
  • Serotyping

Substances

  • Anti-Infective Agents
  • Ciprofloxacin